<unk>  is a cancer vaccine containing a canary pox virus<unk>  combined with the carcinoembryonic antigen <unk>  human gene. A phase I trial in 118 patients showed safety in humans.
ALVAC-CEA vaccine
Tumor antigen vaccine
BCG vaccine
Dendritic cell-based cancer vaccine
VAMP regimen
DTaP-IPV vaccine
Destination therapy
Vaccine therapy